NET PROFIT (x1000 EUR)
EMPLOYEES
Scanpharm A/S
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-594
|
-821
|
-1,450 |
Total assets |
4,240
|
3,988
|
3,888 |
Current assets |
2,356
|
2,169
|
1,963 |
Current liabilities |
3,552
|
3,396
|
3,155 |
Equity capital |
201
|
202
![]() |
202 |
- share capital |
403
![]() |
403
![]() |
403 |
Employees (average) |
75
![]() |
75
![]() |
75 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
4.7%
|
5.1%
|
5.2% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio |
66.3%
|
63.9%
|
62.2% |
Return on equity (ROE) |
-295.5%
|
-406.4%
|
-717.8% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.